Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    New Paper Suggests Vices, Firearms Knock 1.6 Years Off US Life Expectancy

    Longevity and Mortality Risk Transfer October 9, 2024By Aaron Woolner
    Share
    Twitter LinkedIn Email

    Despite spending $4.5trn a year – or $13,400 a person on healthcare – US life expectancy at birth is 77.6 years, one of the lowest among 38 member states of the Organisation of Economically Developed Nations, according to Narrowing the Gap: The Burden of Alcohol, Drugs, and Firearms on U.S. Life Expectancy, a new paper from The Research and Action Institute at the AAMC (Association of American Medical Colleges). 

    The OECD average life expectancy in 2022 is 80.6, and the US figures are over six years below Japan (84.1). In all, more than 27 OECD member states have a life expectancy at birth greater than 80 years and the handful of countries behind the US include Hungary, the Slovak Republic, and Latvia.  

    Kendal Ogera was lead researcher on the paper, which reported that not only was the US performing worse than its peer group of advanced economy states, but the gap has also widened over the last two years. 

    The paper said that in 2022, there were more than 48,000 firearm-related deaths (more than half were recorded as suicides, according to a soon to be published analysis by the AAMC), close to 108,000 drug-related deaths; and more than 51,000 alcohol-induced deaths.  

    “While these numbers made up a small fraction of the nearly 3.3 million deaths in 2022 in the United States, they disproportionately affected children and younger adults — and, as a result, lowered the U.S. life expectancy at birth. If these deaths were eliminated (and other causes of death remained the same), life expectancy at birth would increase by 1.6 years,” the paper said.  

    The AAMC paper said that alcohol, drugs, and firearms deaths in the US were far higher than other countries, and it consistently led the world for the highest level of gun-related deaths in children and teenagers, which were over 9.5 times the rate of Canada in 2021. 

    The paper says that the issue of firearm related deaths in the US appears to be worsening and is now the leading cause of mortality among people aged one to 19 – previously it was unintentional injuries, a category which includes incidents such as car accidents.  

    The US has also had a long term issue with prescription drug use – in 2017 the opioid crisis was classified as a public health emergency by the US government, a status that remains in place.  

    The AAMC research said drug use – including opioids – was the leading cause of death for Americans aged one to 44 years old. According to the latest data from the World Health Authority drug deaths  stood at 31.8 per 100,000 in the US. 

    This figure was significantly higher than neighbouring Canada (19.2) and over 15 times higher than Spain which recorded just 2.1 deaths per 100,000. Despite Scotland recording the highest level of drug deaths in Europe in 2023, the figure for the UK as a whole was 8.4 per 100,00. 

    According to the paper, drug-related deaths were the single biggest factor in reducing US life expectancy at birth figures. The think tank said that if no drug deaths had occurred the average American could expect to live nearly a year longer. 

    “The United States would add an average of 0.4 years and 0.3 years of life expectancy if firearm-related and alcohol-induced deaths, respectively, were eliminated. Younger Americans would see the greatest opportunity for gaining potential years of life if these causes of death were eliminated, though each age group would be impacted to some degree if deaths due to alcohol, drugs, or firearms were eliminated or reduced,” the paper said.  

    There is a wide disparity in drug deaths across the US with the AAMC research indicating that an elimination of substance-linked mortality could spark an even bigger increase in life expectancy in certain jurisdictions.  

    West Virginia, Delaware and Washington DC would each see a 1.4 year jump in life expectancy if drug deaths were eliminated whereas in New Mexico, Alaska, and South Dakota, eliminating alcohol deaths would result in the greatest increase in life expectancy.  

    “In Louisiana, Mississippi, and New Mexico, residents would see the largest gains in life expectancy by eliminating deaths due to firearms,” said the paper. “Overall, 10 states and the District of Columbia would see a jump of at least two years in life expectancy if deaths due to alcohol, drugs, and firearms did not occur, ranging from 2.0 years in South Carolina to 3.0 years in New Mexico.” 

    There was also a significant disparity between ethnic groups. Taking the US as a whole, American Indian, Alaska Native, Black, White, and Hispanic populations would see the largest increases in life expectancy if alcohol, drug, and firearm-related deaths were eliminated.   

    It would only have a minimal impact on Asian populations and there would be no difference to the life expectancy of Native Hawaiian and other Pacific Islander populations would not see any impact on life expectancy.  

    The study did not look at socioeconomic causes for the differences in life expectancy.  

    The AARC report said that while it was impossible to eliminate deaths linked to drugs, alcohol, and firearms, relatively limited progress would have a material impact on increasing the US life expectancy at birth figures.  

    “Federal and state policies can help decrease these deaths and improve life expectancy for all. Reducing causes of death that disproportionately impact children, and young people is particularly important, since youth death rates have the greatest impact on the nation’s average life expectancy. Even a slight reduction in deaths due to the three causes listed above would bring the United States’ life expectancy at birth closer to the OECD average.” 

    2024 - October Clinical Mortality Mortality Risk Volume 3 Issue 10 - October 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026By Mark McCord

    The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

    June 10, 2026By Mark McCord

    Shaping the Future of Health Insurance Through Innovation and Analytics

    June 10, 2026By Jessica Plewes and Lisa Balboa

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026By LMI Newsdesk
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.